Provided by Tiger Trade Technology Pte. Ltd.

CervoMed

2.61
-0.1200-4.40%
Post-market: 2.670.0600+2.30%19:58 EDT
Volume:448.46K
Turnover:1.18M
Market Cap:39.46M
PE:-0.82
High:2.82
Open:2.82
Low:2.55
Close:2.73
52wk High:11.25
52wk Low:2.13
Shares:15.12M
Float Shares:11.20M
Volume Ratio:0.97
T/O Rate:4.01%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-3.1959
EPS(LYR):-2.9824
ROE:-107.62%
ROA:-60.80%
PB:1.72
PE(LYR):-0.88

Loading ...

CervoMed Announces $10 Million Registered Direct Offering of Common Stock Priced At-The-Market Under Nasdaq Rules

GlobeNewswire
·
Jun 19

NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 10:11 AM

Reuters
·
Jun 18

CervoMed Gains New Patent for Neflamapimod Dementia Therapy

TIPRANKS
·
Jun 18

CervoMed Receives Notice of Allowance for Neflamapimod Patent in Dementia With Lewy Bodies

MT Newswires Live
·
Jun 18

CervoMed - Patent Expected to Provide Ip Protection Into 2042

THOMSON REUTERS
·
Jun 18

CervoMed Secures New U.S. Patent Protecting Use of Neflamapimod in Pure Dementia With Lewy Body Patients Into 2042

THOMSON REUTERS
·
Jun 18

CervoMed wins U.S. patent allowance for neflamapimod use in pure Lewy body dementia into 2042

Reuters
·
Jun 18

Top Midday Gainers

MT Newswires Live
·
Jun 17

CervoMed Jumps 29% Pre-Bell After Reporting to SEC Insider Purchase Worth $3 Million Late Monday

MT Newswires Live
·
Jun 16

Major Insider Move at CervoMed Signals Strong Confidence From the Top

TIPRANKS
·
Jun 16

CervoMed Posts Updated Investor Presentation and Business Overview

TIPRANKS
·
Jun 16

CervoMed beneficial owner Joshua S. Boger acquires 955,414 common shares for $2,999,999.96

Reuters
·
Jun 16

CervoMed to Participate in the H.C. Wainwright 7th Annual Neuro Perspectives Expert Summit

GlobeNewswire
·
Jun 12

Roth MKM Reaffirms Their Buy Rating on CervoMed (CRVO)

TIPRANKS
·
Jun 12

CervoMed Announces Private Placement to Advance Neurology Pipeline

TIPRANKS
·
Jun 10

CervoMed releases corporate presentation highlighting neflamapimod Phase 2b efficacy signal in dementia with Lewy bodies

Reuters
·
Jun 10

CervoMed announces $10.5M private placement

TIPRANKS
·
Jun 10

CervoMed prices unregistered $10.5 million private placement at $3.14 per unit

Reuters
·
Jun 10

CervoMed - Announces Private Placement With Anticipated Gross Proceeds of $10.5 Mln

THOMSON REUTERS
·
Jun 10

CervoMed Announces Private Placement Financing and Plan to Focus on Strategic Partnering to Advance Neflamapimod Into Phase 3 for Dementia With Lewy Bodies

THOMSON REUTERS
·
Jun 10